跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Allersaph-5 - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Allersaph-5
Approved
STANDARD
Allersaph-5
Enicar Pharmaceuticals Pvt. Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
a895cba10da8210f
Company
Enicar Pharmaceuticals Pvt. Ltd.
Type
Standard
Approval Details
Approval Id
a895cba10da8210f
Drug Approval Philippines Name
Allersaph-5
Product Name
Allersaph-5
Registration Number
DRP-9296
Brand Name
Allersaph-5
Generic Name
Loratadine
Dosage Form
Syrup
Dosage Strength
5 mg/5 mL
Manufacturer
Enicar Pharmaceuticals Pvt. Ltd.
Trader
Sapphire Lifesciences Pvt. Ltd.
Importer
Nelpa Lifesciences, Inc.
Distributor
Nelpa Lifesciences, Inc.
Issuance Date
29 May 2025
Expiry Date
29 May 2030
Pharmacologic Category
Antihistamine
Classification
Over-the-Counter (OTC) Drug
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
a895cba10da8210f
Type
Standard
Back to Philippines FDA Approvals